Will Chevron Acquire Hess?
Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…
Buy
57
ITCI Quote, Financials, Valuation and Earnings
Last price:
$131.75
Seasonality move
:
14.29%
Day range:
$131.58 - $131.71
52-week range:
$64.09 - $131.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
19.96x
P/B ratio:
12.19x
Volume:
661K
Avg. volume:
2M
1-year change:
90.81%
Market cap:
$14B
Revenue:
$680.5M
EPS (TTM):
-$0.73
ITCI Analysts' Consensus Rating
The 11 analysts providing 12-month price projections for Intra-Cellular Therapies shares anticipate an average target of $132.00, ranging from a low estimate of $132.00 to a high estimate of $132.00. This average target implies a growth of 0.23% compared to the current stock price of $131.70.
Consensus Price Target
$132.00
Highest Price Target
$132.00
Lowest Price Target
$132.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 9 | 2 | 2 |
| Hold | 2 | 10 | 9 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Hold | Hold |
ITCI Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Progressive Stock Go Down?
Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…
Why Did StoneCo Stock Go Up So Much?
Brazilian fintech company StoneCo (NASDAQ:STNE) has been on a tear…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
47
RGC alert for Mar 25
Regencell Bioscience Holdings [RGC] is up 7.32% over the past day.
Buy
54
AZEK alert for Mar 25
The AZEK [AZEK] is up 0.43% over the past day.
Sell
36
MPTI alert for Mar 25
M-Tron Industries [MPTI] is up 6.27% over the past day.
